Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy.

Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy.

Item
http://www.wikidata.org/entity/Q43871588
Treatment of Generalized Convulsive Status Epilepticus in Pediatric PatientsA retrospective analysis of glycol and toxic alcohol ingestion: utility of anion and osmolal gaps.Propylene glycol-associated renal toxicity from lorazepam infusion.Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit.Propylene glycol toxicity in children.A rapid analysis of plasma/serum ethylene and propylene glycol by headspace gas chromatography.Trimethoprim/Sulfamethoxazole-Induced Severe Lactic Acidosis: A Case Report and Review of the Literature.Sedation, analgesia, and delirium in the critically ill patient.Persistent lactic acidosis after chronic topical application of silver sulfadiazine in a pediatric burn patient: a review of the literature.Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation.Propylene Glycol Toxicity in Adolescent with Refractory Myoclonic Status Epilepticus.Acute tubular necrosis associated with propylene glycol from concomitant administration of intravenous lorazepam and trimethoprim-sulfamethoxazole.Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity.A prospective evaluation of propylene glycol clearance and accumulation during continuous-infusion lorazepam in critically ill patients.Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit.Drug-induced hyperlactatemia.
P2860

Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy.

Item
http://www.wikidata.org/entity/Q43871588
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Removal of propylene glycol an ...... se lorazepam infusion therapy.
@en
Removal of propylene glycol an ...... se lorazepam infusion therapy.
@nl
type
label
Removal of propylene glycol an ...... se lorazepam infusion therapy.
@en
Removal of propylene glycol an ...... se lorazepam infusion therapy.
@nl
prefLabel
Removal of propylene glycol an ...... se lorazepam infusion therapy.
@en
Removal of propylene glycol an ...... se lorazepam infusion therapy.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Removal of propylene glycol an ...... ose lorazepam infusion therapy
@en
P2093
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921